Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.
Shared 3 weeks ago
101 views
Shared 1 month ago
201 views
Shared 1 month ago
375 views
Shared 2 months ago
508 views
Shared 2 months ago
499 views
Shared 2 months ago
524 views
Shared 3 months ago
144K views
Shared 3 months ago
457 views
Shared 4 months ago
352 views
Shared 4 months ago
209K views
Shared 5 months ago
297 views
Shared 7 months ago
473K views
Shared 7 months ago
211 views
Shared 7 months ago
91 views
Shared 8 months ago
691 views
Shared 8 months ago
1.7K views
Shared 9 months ago
413 views
Shared 10 months ago
582 views
Shared 10 months ago
117K views
Shared 11 months ago
152 views
Shared 11 months ago
41K views
Shared 11 months ago
351 views
Shared 11 months ago
103K views